Global Intravenous Immunoglobulin Market Size & Outlook

The intravenous immunoglobulin industry worldwide is expected to reach a projected revenue of US$ 21,010.4 million by 2030. A compound annual growth rate of 7.3% is expected of the worldwide intravenous immunoglobulin industry from 2024 to 2030.
Revenue, 2023 (US$M)
$12,862.9
Forecast, 2030 (US$M)
$21,010.4
CAGR, 2024 - 2030
7.3%
Report Coverage
Worldwide

Global intravenous immunoglobulin market, 2018-2030 (US$M)

Global intravenous immunoglobulin market highlights

  • The global intravenous immunoglobulin market generated a revenue of USD 12,862.9 million in 2023 and is expected to reach USD 21,010.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 7.3% by 2030.
  • In terms of segment, immunodeficiency diseases accounted for a revenue of USD 2,577.5 million in 2023.
  • Kawasaki Disease is the most lucrative application segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.


Global data book summary

Market revenue in 2023USD 12,862.9 million
Market revenue in 2030USD 21,010.4 million
Growth rate7.3% (CAGR from 2023 to 2030)
Largest segmentImmunodeficiency diseases
Fastest growing segmentKawasaki Disease
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunodeficiency diseases, CIDP, Hypogammaglobulinemia, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome


Other key industry trends

  • In terms of revenue, the North America accounted for 46.4% of the global intravenous immunoglobulin market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Norway is the fastest growing regional market and is projected to reach USD 79.5 million by 2030.

Immunodeficiency diseases was the largest segment with a revenue share of 20.04% in 2023. Horizon Databook has segmented the Global intravenous immunoglobulin market based on immunodeficiency diseases, cidp, hypogammaglobulinemia, congenital aids, chronic lymphocytic leukemia, myasthenia gravis, multifocal motor neuropathy, itp, kawasaki disease, guillain-barre syndrome covering the revenue growth of each sub-segment from 2018 to 2030.


Market Dynamics

Primary Immune Deficiency (PID) diseases represent a group of disorders characterized by a complete lapse in the immune system. There are over 430 different PIDs such as specific antibody deficiency, X-ined hypogammaglobulinemia, Wiscott -Aldrich syndrome, Di George syndrome, and Ataxia-telangectasia, among others. 

The most common uses of intravenous immunoglobulin are seen the treatment of Gullian Barre syndrome, multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy, dermatomyositis and inflammatory myopathies, Myasthenia gravis, Lambert & Eaton syndrome, and stiff person syndrome, among others. As per a study published by U.S. 

National Library of Medicine and National Institute of Health, approximately 6 million patients are typically affected by PID worldwide with almost 90% of these cases remaining undiagnosed. Individuals suffering from PIDs are therefore vulnerable to other infections and other severe autoimmunity, malignancy, auto inflammation, and allergies.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intravenous Immunoglobulin Market Companies

Name Profile # Employees HQ Website

Global intravenous immunoglobulin market size, by regions, 2018-2030 (US$M)

Top 10 countries: Intravenous immunoglobulin market size, 2023 (US$M)

Global intravenous immunoglobulin market share, by application, 2023 & 2030 (%, US$M)

Intravenous immunoglobulin market: Opportunity assessment by country

Global intravenous immunoglobulin market, by region, 2023 (US$M)

Global intravenous immunoglobulin market size, by regions, 2018-2030 (US$M)

Application 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 4,524.7 4,805.3 5,104.7 5,196.1 5,571.2 5,968.7 6,389.5 6,834.8 7,305.3 7,802.2 8,325.8 8,877.6 9,455.8 6.8%
Europe 2,408.0 2,560.4 2,723.1 2,775.2 2,979.1 3,195.5 3,424.9 3,667.9 3,925.1 4,197.0 4,484.1 4,787.2 5,106.6 6.9%
Asia Pacific 2,093.3 2,255.6 2,431.1 2,510.7 2,731.3 2,968.8 3,224.5 3,499.5 3,795.0 4,112.2 4,450.9 4,813.8 5,201.7 8.3%
Latin America 314.5 338.1 363.6 374.7 406.7 441.0 477.9 517.4 559.8 605.2 653.7 705.4 760.1 8.1%
MEA 203.4 220.0 237.5 245.4 266.6 288.9 312.4 336.9 362.6 389.3 419.2 450.4 486.2 7.7%
Overall 9,543.9 10,179.4 10,860.0 11,102.1 11,954.8 12,862.9 13,829.1 14,856.5 15,947.8 17,106.0 18,333.7 19,634.3 21,010.4 7.3%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more